Paraneoplastic and metastatic neurologic complications of Merkel cell carcinoma

Mayo Clinic Proceedings

Volumn 76, Issue 3, 2001, Pages 327-330

  Eggers, Scott D Z ^a   Salomao, Diva R ^b   Dinapoli, Robert P ^b   Vernino, Steven ^a  

^a Department of Neurology ^*  (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN METASTASIS; CARCINOMATOUS MENINGITIS; CASE REPORT; CLINICAL EXAMINATION; EATON LAMBERT SYNDROME; FEMORAL NERVE; HISTOPATHOLOGY; HUMAN; MALE; MERKEL CELL TUMOR; NERVE CONDUCTION; NEUROLOGICAL COMPLICATION; PARANEOPLASTIC NEUROPATHY;

EID: 0035097977     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.3.327     Document Type: Article

References (17)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972; 105:107-110.
2. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer. 1978;42:2311-2321.
3. Voog E, Biron P, Martin J-P, Blay J-Y. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer. 1999;85:2589-2595.
4. Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin, I: a clinicopathologic and ultrastructural study of 43 cases. Am J Surg Pathol. 1985;9:95-108.
5. Ikawa F, Kiya K, Uozumi T, et al. Brain metastasis of Merkel cell carcinoma: case report and review of the literature. Neurosurg Rev. 1999;22:54-57.
6. Kennelly KD, Dodick DW, Pascuzzi RM, Albain KS, Lennon VA. Neuronal autoantibodies and paraneoplastic neurological syndromes associated with extrapulmonary small cell carcinoma [abstract]. Neurology. 1997;48(3, suppl):A31-A32. Abstract PO 1.018.
7. Lennon VA. Serologie profile of myasthenia gravis and distinction from the Lambert-Eaton myasthénie syndrome. Neurology. 1997; 48(suppl 5):S23-S27.
8. Katz JS, Wolfe GI, Bryan WW, Tintner R, Barohn RJ. Acetylcholine receptor antibodies in the Lambert-Eaton myasthénie syndrome. Neurology. 1998;50:470-475.
9. Galanis E, Frytak S, Rowland KM Jr, Sloan JA, Lennon VA. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy. Cancer Immunol Immunother. 1999;48:85-90.
10. Gallon C, Thomson D, Boyle R. Lambert-Eaton myasthénie syndrome and non-pulmonary small cell carcinoma [letter]. J N enrol Neurosurg Psychiatry. 1998;64:819-820.
11. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg. 1995;21:669-683.
12. Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol. 1997;21:226-234.
13. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol. 1995;8:384-388.
14. Schmidt U, Muller U, Metz KA, Leder LD. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung. Am J Dermatopathol. 1998:20:346-351.
15. Posner JB. Neurologic Complications of Cancer. Philidelphia, Pa: FADavis; 1995.
16. Snodgrass SM, Landy H, Markoe AM, Feun L. Neurologic complications of Merkel cell carcinoma. J Neurooncol. 1994;22:231-234.
17. Dudley TH Jr, Moinuddin S. Cytologie and immunohistochemical diagnosis of neuroendocrine (Merkel cell) carcinoma in cerebrospinal fluid. Am J Clin Pathol. 1989;91:714-717.